1-(3-chlorophenyl)piperazine has been researched along with Bradykinesia in 1 studies
1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.
Excerpt | Relevance | Reference |
---|---|---|
" In the present study, we investigated whether chronic administration of fluvoxamine desensitizes 5-HT2C receptors using a putative in vivo rat model of 5-HT2C receptor function." | 1.32 | Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats. ( Imanishi, T; Kojima, M; Nagase, K; Tatebayashi, T; Yamauchi, M, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yamauchi, M | 1 |
Tatebayashi, T | 1 |
Nagase, K | 1 |
Kojima, M | 1 |
Imanishi, T | 1 |
1 other study available for 1-(3-chlorophenyl)piperazine and Bradykinesia
Article | Year |
---|---|
Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Fluvoxamine; Hypokinesia; Male; Motor Activity; Pa | 2004 |